Regeneron Pharmaceuticals (REGN -0.7%) announces that the FDA has approved Eylea Injection for...

|About: Regeneron Pharmaceuticals, ... (REGN)|By:, SA News Editor

Regeneron Pharmaceuticals (REGN -0.7%) announces that the FDA has approved Eylea Injection for the treatment of macular edema. The approval was based on data from Phase 3 studies which showed results for Eylea were superior to those for the sham control group for the primary endpoint.